Načítá se...
Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
Temozolomide (TMZ) is an alkylating agent used in the treatment of high-grade malignant glioma, notably glioblastoma multiforme, the most aggressive form of brain cancer. The drug induces a dozen DNA methylation adducts, including O(6)-methylguanine (O(6)MeG), which is the most toxic primary DNA les...
Uloženo v:
| Vydáno v: | Int J Mol Sci |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6480213/ https://ncbi.nlm.nih.gov/pubmed/30925722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20071562 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|